Literature DB >> 23984022

Characteristics of hepatitis B infection in a sample of omani patients.

Khalid Al-Naamani1, Ali Al-Maqbali, Siham Al-Sinani.   

Abstract

OBJECTIVES: This study aimed to describe the demographic and virological characteristics of chronic hepatitis B virus (HBV) infection in a sample of Omani patients, and indirectly assess the efficacy of hepatitis B vaccination programmes and catch-up strategies.
METHODS: A retrospective study was undertaken of all patients with chronic HBV infections evaluated and followed-up at the Hepatology Clinic of the Armed Forces Hospital (AFH), Muscat, Oman, between January 2009 and April 2011.
RESULTS: A total of 154 patients met the inclusion criteria. The mean age of infected patients was 33 years with 72.7% being over 27 years. Females constituted 47.7% of the patients. Half of the cohort was referred either from the AFH's Obstetric Clinic (29.2%) or its Blood Bank (22.1%). A family history of chronic HBV infection was present in 70% of patients. A total of 95% had positive hepatitis B surface antigens, while only 5% had isolated total hepatitis B core antibodies. Most patients (96%) were hepatitis B e-antigen-negative. The majority (77.9%) had low HBV dioribonucleic acid levels of <2,000 IU/ml. Radiological features of liver cirrhosis were observed in 5%. Patients requiring treatment were in the minority (9%).
CONCLUSION: Almost 50% of the infected patients were female, the majority being of childbearing age. Medical authorities in Oman should consider enforcing a screening policy for all pregnant women using complete hepatitis B serological testing.

Entities:  

Keywords:  Blood Donors; Hepatitis B Vaccines; Hepatitis B, Chronic; Hepatitis B, prevention and control; Oman

Year:  2013        PMID: 23984022      PMCID: PMC3749021          DOI: 10.12816/0003259

Source DB:  PubMed          Journal:  Sultan Qaboos Univ Med J        ISSN: 2075-051X


  37 in total

Review 1.  Hepatitis B virus infection.

Authors:  W M Lee
Journal:  N Engl J Med       Date:  1997-12-11       Impact factor: 91.245

2.  Prevention of hepatocellular carcinoma by universal vaccination against hepatitis B virus: the effect and problems.

Authors:  Mei-Hwei Chang; Tony Hsiu-Hsi Chen; Hsu-Mei Hsu; Tzee-Chung Wu; Man-Shan Kong; Der-Cherng Liang; Yen-Hsuan Ni; Chien-Jen Chen; Ding-Shinn Chen
Journal:  Clin Cancer Res       Date:  2005-11-01       Impact factor: 12.531

3.  Hepatitis B vaccination in children: the Taiwan experience.

Authors:  Y-H Ni; D-S Chen
Journal:  Pathol Biol (Paris)       Date:  2010-01-29

4.  Failure of Centers for Disease Control criteria to identify hepatitis B infection in a large municipal obstetrical population.

Authors:  M M Jonas; E R Schiff; M J O'Sullivan; M de Medina; K R Reddy; L J Jeffers; T Fayne; K C Roach; B W Steele
Journal:  Ann Intern Med       Date:  1987-09       Impact factor: 25.391

5.  A mathematical model to estimate global hepatitis B disease burden and vaccination impact.

Authors:  Susan T Goldstein; Fangjun Zhou; Stephen C Hadler; Beth P Bell; Eric E Mast; Harold S Margolis
Journal:  Int J Epidemiol       Date:  2005-10-25       Impact factor: 7.196

Review 6.  Global control of hepatitis B virus infection.

Authors:  Jia-Horng Kao; Ding-Shinn Chen
Journal:  Lancet Infect Dis       Date:  2002-07       Impact factor: 25.071

7.  The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response.

Authors:  B Rehermann; C Ferrari; C Pasquinelli; F V Chisari
Journal:  Nat Med       Date:  1996-10       Impact factor: 53.440

8.  Hepatitis B vaccine in health care personnel: safety, immunogenicity, and indicators of efficacy.

Authors:  J L Dienstag; B G Werner; B F Polk; D R Snydman; D E Craven; R Platt; C S Crumpacker; R Ouellet-Hellstrom; G F Grady
Journal:  Ann Intern Med       Date:  1984-07       Impact factor: 25.391

9.  Role of hepatitis C and delta viruses in the termination of chronic hepatitis B surface antigen carrier state: a multivariate analysis in a longitudinal follow-up study.

Authors:  I S Sheen; Y F Liaw; D Y Lin; C M Chu
Journal:  J Infect Dis       Date:  1994-08       Impact factor: 5.226

10.  Hepatitis B, delta and human immunodeficiency virus infections among Omani patients with renal diseases: A seroprevalence study.

Authors:  S S Al-Dhahry; P N Aghanashinikar; H A Al-Marhuby; M R Buhl; A S Daar; M K Al-Hasani
Journal:  Ann Saudi Med       Date:  1994-07       Impact factor: 1.526

View more
  3 in total

1.  Risk Factors for Hepatitis B Virus Transmission 
in Oman.

Authors:  Said A Al-Busafi; Rahma Al-Harthi; Khalid Al-Naamani; Haifa Al-Zuhaibi; Patricia Priest
Journal:  Oman Med J       Date:  2021-07-31

2.  Hepatocellular Carcinoma in Oman: An analysis of 284 cases.

Authors:  Khalid Al-Naamani; Zamzam Al-Hashami; Omar Al-Siyabi; Mansour Al-Moundri; Bassim Al-Bahrani; Siham Al-Sinani; Ibrahim Al-Zakwani; Heba Omar; Said A Al-Busafi; Haifa Al-Zuhaibi; Abdullah AlMamari; Bola R Kamath; Abdullah Al-Kalbani; Ikram Ali Burney
Journal:  Sultan Qaboos Univ Med J       Date:  2020-10-05

3.  Estimating the proportion of people with chronic hepatitis B virus infection eligible for hepatitis B antiviral treatment worldwide: a systematic review and meta-analysis.

Authors:  Mingjuan Tan; Ajeet S Bhadoria; Fuqiang Cui; Alex Tan; Judith Van Holten; Philippa Easterbrook; Nathan Ford; Qin Han; Ying Lu; Marc Bulterys; Yvan Hutin
Journal:  Lancet Gastroenterol Hepatol       Date:  2020-11-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.